THERO JOHN F 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 7, 2023
Insider Transaction Report
Form 4
THERO JOHN F
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-02-03+12,828→ 12,828 totalExercise: $1.69Exp: 2033-02-03→ Common Stock (12,828 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest in full on February 3, 2024, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.